Sale is live|00:00:00

Kuantum Papers Ltd Q1 FY27 Earnings Analysis

Published 14 Jun 2026 | Paper, Forest & Jute Products | Market Cap: ₹683 Cr

Price

74.8

Market Cap

₹683 Cr

P/E Ratio

12.7

Revenue Rank

Rank 1

Margin Rank

Rank 1

Earnings Summary

- Kuantum Papers expects a volume increase from around 1,62,000 tons to approximately 2,30,000 tons annually, a 40% to 50% rise. - Kuantum Papers expects volume growth from about 162,000 tons to 230,000 tons annually (40%-50% increase).

📊 Revenue & Sales Performance

Rank 1

- Kuantum Papers expects a volume increase from around 1,62,000 tons to approximately 2,30,000 tons annually, a 40% to 50% rise. - Projected top-line revenue is expected to grow to INR1,400-1,500 crores in FY27, gradually reaching INR1,600-1,700 crores by FY28. - The company targets EBITDA margins of about 18% to 20%. - Capacity utilization goal is over 90% as new capacity comes online, supported by a well-established dealer network and exports to Gulf and Northern African markets. - Growth will be partly driven by expansion in specialty paper segments (25%-30% of production) to cater to niche markets. - Upgraded machinery and new capacities will help improve quality, reduce costs, and enable higher realizations. - Management anticipates stabilization and positive pricing trends returning around September after a lean season.

📈 Profitability & Margins

Rank 1

- Kuantum Papers expects volume growth from about 162,000 tons to 230,000 tons annually (40%-50% increase). - Revenue guidance for FY27 is approximately INR 1,400 to 1,500 crores, inching up to INR 1,600 to 1,700 crores by FY28. - EBITDA margin target is between 18% to 20% going forward. - Profit after tax margins are expected to improve from current levels. - Debt is expected to reduce from peak INR 650 crores by INR 100-200 crores annually, aiding profit growth. - Anti-subsidy duty implementation this financial year may lead to reduced import competition, potentially supporting better realizations and volume growth. - Capacity utilization is expected to surpass 90%, supporting volume and earnings growth. - Operational efficiencies and AI integration will help lower production costs, aiding margin expansion. Overall, Kuantum Papers anticipates steady growth in revenues, profitability, and EPS driven by capacity expansion, better product mix, and improved operational performance.

🏗️ Capital Expenditure Plans

No

- Ongoing capex of around INR 125 crores to be completed by FY27, FY28, mainly related to existing expansion projects. - Pulp upgradation being undertaken side by side, expected to come on stream by July 2026 with the PM3 machine. - Capacity expansion ongoing with targeted production increase from ~1,63,000 tons to 2,30,000 tons annually. - No new capex plans currently; focus is on completing existing projects. - Industry 4.0 and AI-based transformation project ("Project Nirmaan") underway to improve operational efficiency, with full AI implementation expected by FY28. - Plant upgradation includes installation of synchro sheeter and commissioning of Displacement Digester System (DDS) expected by mid-June 2026. - Social farm forestry expanded by 854 acres during the quarter, totaling over 18,300 acres. - Possibility of future expansion discussed but no concrete new capex plans disclosed as of now.

💰 Fundraising & Capital Structure

Yes

- No new fundraising through debt or equity is planned currently; the company is focused on managing existing debt and completing ongoing capex. - The company aims to keep debt under control and has a debt repayment schedule of around INR170-180 crores annually for the next 2-3 years. - Peak debt is expected to be INR650-675 crores by end of 2027, reducing thereafter. - Expansion capex of approximately INR125 crores will be completed by FY27. - Management is exploring options to reduce cost of funds, including FCNRB loans or other cheaper debt modes. - No buybacks or equity raises are planned until debt is under control. - The tissue plant project, a potential future investment, is deferred until current operations and debt are stabilized. - Possibility of alternate low-cost capital infusion (e.g., rights or QIP) is being considered, but no immediate plans.

📋 Order Book & Pipeline

No information

The transcript of Kuantum Papers Limited's Q4-FY26/FY26 earnings call does not explicitly mention the current or expected orderbook or pending orders. However, the following insights related to demand and sales outlook can be noted: - The company has a widely spread dealer network of around 90 committed dealers and 20 additional irregular dealers across India. - They are confident about achieving a production and sales volume increase from approximately 1,62,000 tons to 2,30,000 tons annually, indicating strong expected demand absorption. - Incremental volumes are expected to be absorbed through existing dealer network and expansion into global markets such as Gulf and Northern Africa. - Focus on specialty paper segments (25-30% of production) with niche applications is targeted to support volume growth. - Management expresses confidence that selling increased capacity will not be an issue without specifying an order backlog. No specific figures for orderbook or pending orders are disclosed.

Key Metrics

Revenue

Rank 1

Margin

Rank 1

Capex

No

Fundraise

Yes

Order Book

No information

Frequently Asked Questions

What were Kuantum Papers Ltd Q1 FY27 results?

- Kuantum Papers expects a volume increase from around 1,62,000 tons to approximately 2,30,000 tons annually, a 40% to 50% rise. - Kuantum Papers expects volume growth from about 162,000 tons to 230,000 tons annually (40%-50% increase).

What is Kuantum Papers Ltd share price analysis?

Kuantum Papers Ltd currently shows a strong growth signal based on ranking data. The stock trades at a P/E of 12.7 with a market cap of ₹683. Investors should review the full earnings analysis for detailed insights.

Is Kuantum Papers Ltd planning capital expenditure?

- Ongoing capex of around INR 125 crores to be completed by FY27, FY28, mainly related to existing expansion projects.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.